Explore our featured stock ideas and investment opportunities to make informed decisions in today's market.
View AllLatest VR Adviser, LLC Stock Portfolio
$1.46Billion
Equity Portfolio Value
Last Reported on: 14 Feb, 2024
About VR Adviser, LLC and it’s 13F Hedge Fund Stock Holdings
VR Adviser, LLC is a hedge fund based in New York, NY. On 30-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $2.4 Billions. In it's latest 13F Holdings report, VR Adviser, LLC reported an equity portfolio of $949.9 Millions as of 30 Sep, 2023.
The top stock holdings of VR Adviser, LLC are , , VRDN. The fund has invested 19% of it's portfolio in APOGEE THERAPEUTICS INC and 9.4% of portfolio in RAYZEBIO INC.
The fund managers got completely rid off THESEUS PHARMACEUTICALS INC (THRX), BLACK DIAMOND THERAPEUTICS I (BDTX) and AVALO THERAPEUTICS INC (AVTX) stocks. They significantly reduced their stock positions in GH RESEARCH PLC. VR Adviser, LLC opened new stock positions in APOGEE THERAPEUTICS INC, TAYSHA GENE THERAPIES INC (TSHA) and HILLEVAX INC (HLVX). The fund showed a lot of confidence in some stocks as they added substantially to ADVERUM BIOTECHNOLOGIES INC (ADVM), ENLIVEN THERAPEUTICS INC and AEGLEA BIOTHERAPEUTICS INC (AGLE).
The top stock holdings of VR Adviser, LLC are , , VRDN. The fund has invested 19% of it's portfolio in APOGEE THERAPEUTICS INC and 9.4% of portfolio in RAYZEBIO INC.
The fund managers got completely rid off THESEUS PHARMACEUTICALS INC (THRX), BLACK DIAMOND THERAPEUTICS I (BDTX) and AVALO THERAPEUTICS INC (AVTX) stocks. They significantly reduced their stock positions in GH RESEARCH PLC. VR Adviser, LLC opened new stock positions in APOGEE THERAPEUTICS INC, TAYSHA GENE THERAPIES INC (TSHA) and HILLEVAX INC (HLVX). The fund showed a lot of confidence in some stocks as they added substantially to ADVERUM BIOTECHNOLOGIES INC (ADVM), ENLIVEN THERAPEUTICS INC and AEGLEA BIOTHERAPEUTICS INC (AGLE).
New Buys
| Ticker | $ Bought |
|---|---|
| SPYRE THERAPEUTICS INC | 51,060,800 |
| OCULAR THERAPEUTIX INC | 34,679,900 |
| AMBRX BIOPHARMA INC | 29,476,800 |
| ARVINAS INC | 25,839,800 |
| ASTRIA THERAPEUTICS INC | 24,774,200 |
| ABIVAX SA | 10,684,700 |
| PRAXIS PRECISION MEDICINES I | 7,878,790 |
| EYEPOINT PHARMACEUTICALS INC | 5,777,500 |
New stocks bought by VR Adviser, LLC
Additions
| Ticker | % Inc. |
|---|---|
| LYRA THERAPEUTICS INC | 178 |
| PHARVARIS N V | 117 |
| TERNS PHARMACEUTICALS INC | 45.43 |
| KALVISTA PHARMACEUTICALS INC | 40.32 |
| CABALETTA BIO INC | 29.94 |
| VIRIDIAN THERAPEUTICS INC | 25.95 |
| MERUS N V | 24.45 |
| 4D MOLECULAR THERAPEUTICS IN | 14.13 |
Additions to existing portfolio by VR Adviser, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| MILESTONE PHARMACEUTICALS IN | -58.12 |
| RHYTHM PHARMACEUTICALS INC | -54.5 |
| GH RESEARCH PLC | -51.96 |
| SAVARA INC | -51.29 |
| TAYSHA GENE THERAPIES INC | -27.91 |
| ADVERUM BIOTECHNOLOGIES INC | -21.69 |
| CELCUITY INC | -10.44 |
VR Adviser, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| PRAXIS PRECISION MEDICINES I | -9,070,540 |
| TRAVERE THERAPEUTICS INC | -23,455,700 |
| AMBRX BIOPHARMA INC | -23,805,000 |
| AFFIMED N V | -682,714 |
| ACLARIS THERAPEUTICS INC | -7,129,160 |
| SAGIMET BIOSCIENCES INC | -4,532,000 |
| AEGLEA BIOTHERAPEUTICS INC | -3,614,170 |
| PLIANT THERAPEUTICS INC | -5,010,380 |
VR Adviser, LLC got rid off the above stocks
Current Stock Holdings of VR Adviser, LLC
Last Reported on: 14 Feb, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ACRS | ACLARIS THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | 0.27 | 5,147,550 | 3,875,070 | REDUCED | -21.69 | |
| AFMD | AFFIMED N V | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| AGLE | SPYRE THERAPEUTICS INC | 3.50 | 2,372,710 | 51,060,800 | NEW | ||
| AGLE | AEGLEA BIOTHERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| AMAM | AMBRX BIOPHARMA INC | 2.02 | 2,070,000 | 29,476,800 | NEW | ||
| AMAM | AMBRX BIOPHARMA INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| APLT | APPLIED THERAPEUTICS INC | 1.44 | 6,250,000 | 20,937,500 | ADDED | 10.46 | |
| ARVN | ARVINAS INC | 1.77 | 627,788 | 25,839,800 | NEW | ||
| ATXS | ASTRIA THERAPEUTICS INC | 1.70 | 3,225,810 | 24,774,200 | NEW | ||
| CABA | CABALETTA BIO INC | 3.99 | 2,563,950 | 58,201,700 | ADDED | 29.94 | |
| CELC | CELCUITY INC | 1.88 | 1,885,540 | 27,472,300 | REDUCED | -10.44 | |
| COGT | COGENT BIOSCIENCES INC | 1.89 | 4,684,170 | 27,542,900 | UNCHANGED | 0.00 | |
| DYN | DYNE THERAPEUTICS INC | 1.98 | 2,173,910 | 28,913,000 | UNCHANGED | 0.00 | |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 0.40 | 250,000 | 5,777,500 | NEW | ||
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 4.76 | 3,424,030 | 69,370,900 | ADDED | 14.13 | |
| GHRS | GH RESEARCH PLC | 0.52 | 1,318,330 | 7,646,300 | REDUCED | -51.96 | |
| HLVX | HILLEVAX INC | 2.28 | 2,075,000 | 33,303,800 | ADDED | 1.85 | |
| KALV | KALVISTA PHARMACEUTICALS INC | 3.44 | 4,092,730 | 50,136,000 | ADDED | 40.32 | |
| LYRA | LYRA THERAPEUTICS INC | 0.93 | 2,575,590 | 13,496,100 | ADDED | 178 | |
| MIST | MILESTONE PHARMACEUTICALS IN | 0.11 | 925,048 | 1,544,830 | REDUCED | -58.12 | |
| MRSN | MERSANA THERAPEUTICS INC | 1.80 | 11,328,000 | 26,281,000 | UNCHANGED | 0.00 | |
| MRUS | MERUS N V | 4.05 | 2,148,210 | 59,075,900 | ADDED | 24.45 | |
| OCUL | OCULAR THERAPEUTIX INC | 2.38 | 7,775,760 | 34,679,900 | NEW | ||
| OLMA | OLEMA PHARMACEUTICALS INC | 0.07 | 77,042 | 1,080,900 | UNCHANGED | 0.00 | |
| ORIC | ORIC PHARMACEUTICALS INC | 1.53 | 2,428,380 | 22,341,100 | ADDED | 13.32 | |
| PHVS | PHARVARIS N V | 6.53 | 3,395,610 | 95,246,800 | ADDED | 117 | |
| PLRX | PLIANT THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| PRAX | PRAXIS PRECISION MEDICINES I | 0.54 | 353,626 | 7,878,790 | NEW | ||
| PRAX | PRAXIS PRECISION MEDICINES I | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| RLYB | RALLYBIO CORP | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| RYTM | RHYTHM PHARMACEUTICALS INC | 1.56 | 495,983 | 22,800,300 | REDUCED | -54.5 | |
| SVRA | SAVARA INC | 1.13 | 3,500,000 | 16,450,000 | REDUCED | -51.29 | |
| TERN | TERNS PHARMACEUTICALS INC | 2.00 | 4,497,120 | 29,186,300 | ADDED | 45.43 | |
| TRVI | TREVI THERAPEUTICS INC | 0.32 | 3,422,400 | 4,586,010 | UNCHANGED | 0.00 | |
| TSHA | TAYSHA GENE THERAPIES INC | 1.26 | 10,412,900 | 18,430,800 | REDUCED | -27.91 | |
| TVTX | TRAVERE THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| VRDN | VIRIDIAN THERAPEUTICS INC | 5.80 | 3,882,620 | 84,563,500 | ADDED | 25.95 | |
| RAYZEBIO INC | 17.18 | 4,030,470 | 250,574,000 | ADDED | 0.34 | ||
| APOGEE THERAPEUTICS INC | 16.27 | 8,493,320 | 237,303,000 | UNCHANGED | 0.00 | ||
| ENLIVEN THERAPEUTICS INC | 2.81 | 2,954,900 | 40,895,800 | UNCHANGED | 0.00 | ||
| ABIVAX SA | 0.73 | 998,570 | 10,684,700 | NEW | |||
| DIANTHUS THERAPEUTICS INC | 0.66 | 927,706 | 9,648,140 | UNCHANGED | 0.00 | ||
| ACELYRIN INC | 0.48 | 937,113 | 6,990,860 | ADDED | 8.42 | ||
| SAGIMET BIOSCIENCES INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 |